Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-068148
Filing Date
2021-05-17
Accepted
2021-05-17 16:31:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A a21-16614_2defa14a.htm DEFA14A 33410
  Complete submission text file 0001104659-21-068148.txt   34472
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36714 | Film No.: 21931354
SIC: 2834 Pharmaceutical Preparations